About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, August 23rd, 2013

The QualityStocks
Daily Stock List

graphic
graphic

GreenShift Corp. (GERS)

PennyStocks24 and StockMister reported earlier on GreenShift Corp. (GERS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Headquartered inAlpharetta, Georgia, GreenShift Corp. develops and commercializes clean technologies. The design of these is to address the financial and environmental requirements of their clients through decreasing raw material needs, facilitating co-product reuse, and reducing the generation of wastes and emissions. In essence, the Companydevelops and commercializes clean technologies that facilitate the more efficient use of natural resources. GreenShift’s shares trade on the OTCQB.

The Company is focusing on developing and commercializing clean technologies in the U.S. ethanol industry. In this industry, GreenShift innovates and offers technologies that improve the profitability of licensed ethanol producers.GreenShift invented, developed, commercialized and patented new technologies that integrate into the back-end of existing dry mill corn ethanol plants to tap into a new reserve of inedible crude corn oil. This corn oil is a valuable feedstock for use in the production of advanced carbon-neutral liquid fuels and other biomass-derived alternatives to fossil fuel-based products.

The current market value of corn oil recovered by GreenShift’s licensees is approximately $2.85 per gallon. The Company’s corn oil extraction technologies increase corn-to-biofuel yields while reducing the energy and greenhouse gas intensity of corn ethanol production for dry mill ethanol producers. These benefits correspond to increased ethanol producer income of over $0.15 per gallon of ethanol produced, and ethanol producer paybacks of less than one year at current market prices.

In June,GreenShift announced that the Company’s wholly-owned subsidiary, GS CleanTech Corp., filed suit against Pacific Ethanol, Inc., in the Eastern District of California for infringement of GreenShift’s patented corn oil extraction processes. Furthermore, GreenShift announced in June that GS CleanTech filed suit against Guardian Energy, LLC, in the United States District Court for the District of Minnesota for infringement of GreenShift’s patented corn oil extraction processes. GreenShift said they will continue to defend against all infringement of their corn oil extraction patents to protect the competitive advantage of their licensed ethanol plants.

GreenShift Corp. (GERS), closed Friday’s trading session at $0.0007, even for the day, on 8,365,137 volume with 19 trades. The average volume for the last 60 days is 4,893,193 and the stock's 52-week low/high is $0.0007/$0.085.

Municipal Mortgage & Equity, LLC (MMAB)

Wall Street Resources and AllPennyStocks reported previously on Municipal Mortgage & Equity, LLC (MMAB), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Municipal Mortgage & Equity, LLC is a diverse real estate finance company whose shares trade on the OTC Markets’ OTCQB. The Company principallyinvests in tax-exempt bonds secured by affordable housing. They specialize in tax-exempt bonds for the multi-family housing segment. Founded in 1995, Municipal Mortgage & Equityis based in Baltimore, Maryland. 

Municipal Mortgage & Equity (MuniMae) originates mortgage revenue bonds. State and local governments or their agencies or authorities (to finance multifamily housing developments, including affordable housing, student housing, and senior living facilities) issue these types of bonds. 

MuniMae also originates other bonds, chiefly municipal bonds that undergo issuance by community development districts or other municipal issuers to finance the development of community infrastructure supporting single-family housing and mixed-use and commercial developments. This infrastructure includes storm water management systems, roads, and community recreational facilities.

Recently, MuniMaeannounced that they completed a transaction which had the effect of selling the Company's fixed rate performing multifamily bond portfolio and dischargingthe Company of the associated debt and preferred equity obligations. The effective price for the $849 million portfolio was equal to fair value at June 30, 2013 and 101 percent of par. In addition to eliminating $799 million of debt and preferred equity obligations, MuniMae received $79 million in cash. Furthermore, the Company announced that their intention is to convert to a corporation for federal income tax purposes; they intend to expand their current share buyback plan.

Last week, MuniMae announced that they filed their Quarterly Report on Form 10-Q for the quarter ended June 30, 2013 with the Securities and Exchange Commission(SEC) on August 14, 2013. The Company reported common shareholders' equity of $64.6 million at June 30, 2013 ($1.53 per common share). This represents an increase of a $19.7 million from reported common shareholders' equity of $44.9 million at December 31, 2012 ($1.06 per common share).  

Comprehensive income allocable to common shareholders, which includes net income and total other comprehensive income, was a comprehensive loss of $31.2 million for the quarter ended June 30, 2013. This resulted in comprehensive income of $19.0 million for the six months ended June 30, 2013.

Municipal Mortgage & Equity, LLC (MMAB), closed at $1.50, up 8.70%, on 47,792 volume with 49 trades. The average volume for the last 60 days is 114,833 and the stock's 52-week low/high is $0.205/$1.17.

Bio-Solutions Corp. (BISU)

PennyStocks24, Actual Gains, Bullseyestox.com, PricelessPenny, AddictivePennyStocks, and PennyStockRumors.net reported recently on Bio-Solutions Corp. (BISU), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Bio-Solutions Corp.focuses on the development of their Type2 Defense™ product. The Type2 Defense™ product is a natural dietary supplement formulated to support healthy glucose levels for type 2 diabetics and pre-diabetics. Bio-Solutions has their corporate headquarters in San Antonio, Texas. Incorporated in 2007, the Companymarkets organic products; their lead product is the aforementioned Type2 Defense™.

A natural remedy company, Bio-Solutions acquired the Type2 Defense™ brand in September of 2012. This includes all formulas, copyrights, trademarks, records, as well as research. Their focus is currently on type 2 and pre-diabetic products. The targeted market for Type2 Defense™ is health conscious individuals that have been diagnosed as Type II diabetics or individuals who are concerned with pre-diabetic symptoms. TheType2 Defense™ proprietary blend was developed by Dr. Chandrasekhar Mallangi. Dr. Mallangi is a former Nestle’ USA nutritional Innovator and thedeveloper of multiple Nestle’ USA Product lines.

Type 2 Defense™ is a powder blend of natural ingredients. It has undergone development to help support healthy blood glucose levels in health-conscious individuals and those diagnosed with Type II Diabetes.Type2 Defense™ is a nutritional supplement delivered in 10 gram plastic packets packaged in a box of 30 servings.The all natural pure powder mix contains green tea, cinnamon, as well as blueberry flavors, and the Type2 Defense™ proprietary blend. The Company hired Mr. Josh Williams, an independent consultant, to brand Type2Defense™ by way of mainstream media through multiple channels. This includes high-profile, professional athlete endorsements.

In July, Bio-Solutions announced thatthe Company launched their official online retail store at www.Type2Defense.com. Bio-Solutionsisalso maintaining their distribution agreement with the Amazon store Healthy Provisions. Consumers have two options when ordering the product; through the online retail store or Healthy Provisions on Amazon. The Company indicates that this will enable Bio-Solutions to expandtheir consumer base and reach out to clients on an international scale.

Bio-Solutions Corp. (BISU), closed Friday’s trading session at $0.0109, up 36.25%, on 1,186,231 volume with 34 trades. The average volume for the last 60 days is 324,667 and the stock's 52-week low/high is $0.0065/$0.032.

Microelectronics Technology Co. (MELY)

MassiveStockProfits, Fast Moving Stocks, PennyStocks24, Penny Stock Rumble, Penny Trackers, InsideBulls, fusionspicks, RockingPennyStocks, Otcstockexchange, Whisper from Wall Street, TryBestPennyStocks.biz, OtcWizard, and Pennystocknet reported earlier on Microelectronics Technology Co. (MELY), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Listed on the OTC Markets’ OTCQB, Microelectronics Technology Co. is a cloud computing internet technology incubator. They offer cloud technology and services targeting small business. The Company acquired Cloud Data Corp. on August 26, 2011. Microelectronics Technology, via the acquisition of Cloud Data, is operating in the Internet incubator arena to benefit from the technology opportunities available now and in the immediate future within the cloud-computing marketplace. Microelectronics Technology has their headquarters in Del Mar, California.

In September2012, Cloud Datasigned WeatherCity Services as a Server Client. WeatherCity provides weather forecasts to more than 62,000 cities in over 121 countries using their distinctive computer forecasting system. Weather City is forecasting expansion in 2013 to 2 million cities with more than 30 million page views monthly.

In January 2013, Cloud Data announced the launch of their new Dedicated Server Hosting Platform. The Dynamo Servers Platform enables customers to build private clouds and custom Platform as a Service (PaaS) solutions easily. Cloud Data is utilizing the platform to build their Sproq.com Platform as a Service offering.

This past May,Microelectronics Technology announced the establishment of a dedicated sales and marketing division for the Dynamo Server subsidiary.The Sales and Marketing division will operate from the U. S. corporate office. This will allow for the expansion of the Dynamo Server business model to include additional U.S. Points of Presence in Dallas and Chicago over the next two quarters.

Cloud Data is developing and testing their Application hosting architecture SPROQ. SPROQ will featureautomatic load scaling, and users willpay only for what they use, and only if their site is busy. SPROQ featuresintegrated version control and itsupports a broad range of languages and frameworks. It additionally featurestesting and staging instances, andhas pre-built application services that a user can utilize to create their application quickly.Dynamo servers is the basis for the hardware architecture that Sproq.com is built on.

Microelectronics Technology Co. (MELY), closed Friday at $0.0043, even for the day, on 740 volume with 1 trade. The average volume for the last 60 days is 284,626 and the stock's 52-week low/high is $0.0039/$0.05.

mPhase Technologies, Inc. (XDSL)

PennyStocks24 and Bird Gang Stocks reported earlier on mPhase Technologies, Inc. (XDSL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

mPhase Technologies, Inc. develops power cells and related products via the use of microfluidics, microelectromechanical systems, and nano-technology. The Companyis a foremost nanotechnology innovator in Smart Surfaces. Potential applications include energy storage systems, drug delivery systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems.

OTCQB-listed mPhase Technologies has offices in Little Falls, New Jersey; Norwalk,Connecticut, and New York, New York.The Company established in October of 1996 as a spin-off of Microphase Corp. (an RF component technologies leader).

The Companyhas pioneered their first Smart Surface enabled product, the mPhase Smart NanoBattery.The mPhase Smart NanoBattery is ideal for storing energy with essentially unlimited shelf life. Furthermore, mPhase Technologies recently introduced their first product, the mPower Emergency Illuminator. This is an award-winning product designed by Porsche Design Studioof Zell Am See, Austria.

Last month,mPhase Technologiesreleased the Frost & Sullivan report stating that the Company earned the 2013 North American Advanced Battery Technology Innovation Award on June 17, 2013. Frost & Sullivan recognized mPhase Technologieswith the Innovation Award for the Company’s pioneering nanobattery technology.

This week,mPhase Technologies announced that they will be displaying (at SEMA 2013) the Company’s mPower "Jump!" car battery jump starter for channel distribution into specialty, mass retail, and e-tail sales outlets.The SEMA Show is the premier automotive specialty products trade event in Las Vegas, Nevada.

The mPower "Jump! is a portable jump starter that fits in a glove box. The Company believes that the mPower "Jump!" will provide auto channel suppliers and retailers a better solution to jumper cables and traditional car batteries in time for the retail buying seasons.The mPower Jump features advanced battery technology and was created under a Design Development Agreement with Porsche Design Studio. The mPower Jumpis targeted toward the automotive and marine industry.

mPhase Technologies, Inc. (XDSL), closed Friday’s trading session at $0.0012, up 9.09%, on 13,265,007 volume with 27 trades. The average volume for the last 60 days is 6,756,419 and the stock's 52-week low/high is $0.001/$0.0058.

Intellect Neurosciences, Inc. (ILNS)

OtcWizard and Penny PayDay reported previously on Intellect Neurosciences, Inc. (ILNS), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Intellect Neurosciences, Inc. (ILNS)is a biopharmaceutical company whose shares trade on the OTC Markets’ OTCQB. The Companyinvolves in the discovery and development of immunotherapeutic approaches designed to address multifactorial diseases caused by the abnormal folding of proteins, togetherknown as proteinopathies affecting the brain and the eye. Intellect Neurosciencesdevelops inventiveapproaches directed at arresting or preventing Alzheimer's disease and other neurodegenerative diseases, with a particular focus on proteinopathies. Founded in 2005, the Company is based in New York, New York.

Intellect Neurosciencesis concentrating on those proteinopathies. The Company’s pipeline includes small neuroprotective molecules and neoepitope-based immunotherapy approaches, including monoclonal antibodies, antibody drug conjugates, as well as vaccines targeting beta amyloid and abnormal tau proteins.

Intellect’s strategic partnerships include Immuno-Biological Laboratories, Japan;Medical Research Council Technology (MRCT); NYU Medical School and the University of South Alabama Research Foundation, ViroPharma, Inc., and other major pharmaceutical companies.Intellect Neurosciences has granted an exclusive License to ViroPharma regarding certain of Intellect's licensed patents and patent applications related to Intellect’s clinical stage drug candidate, OX1. OX1 is a multimodal, metal-binding, extremely potent antioxidant molecule.Intellect is the exclusive licensee of patents relating to OX1 and OX2 for the treatment of Alzheimer’s and related diseases.

The Company’s platform technologies include ANTISENILIN®, RECALL-VAX™, andCONJUMAB-A. Intellect Neurosciences has granted two worldwide non-exclusive licenses to major pharmaceutical companies with products in Phase II and Phase III clinical under their ANTISENILIN® patents and patent applications. Moreover, Intellect is developing their own follow-on generation product.

The design of the RECALL-VAX™ technology is to reduce or eliminate an autoimmune response and to ensure that antibodies produced by the patient’s immune system only attack the Aβ protein. The Company’s flagship CONJUMAB-A molecule, IN-N01-OX2, is  a non-activating, stabilized IgG4 humanized antibody specific for beta amyloid protein (IN-N01, Intellect’s lead ANTISENILIN molecule) conjugated to as small molecule with neuroprotective properties. 

At the end of July,Intellect Neurosciencesannounced that they retained Chain Pharmaceuticals, LLC as a consultant to assist the company in managing their patent estate and external collaborations and pursuing strategic alternatives. These alternatives may include partnerships, strategic business model alternatives, a sale or other transactions.

Intellect Neurosciences, Inc. (ILNS), closed Friday at $0.0085, down 5.56%, on 582,200 volume with 13 trades. The average volume for the last 60 days is 422,749 and the stock's 52-week low/high is $0.0047/$0.135.

Greystone Logistics, Inc. (GLGI)

Today we are reporting on Greystone Logistics, Inc. (GLGI), here at the QualityStocks Daily Newsletter.

Headquartered in Tulsa, Oklahoma, Greystone Logistics, Inc. is a high-growth "Green" manufacturing and leasing company.The Company reprocesses and sells recycled plastic, and designs, manufactures, sells and leases high-quality 100 percent recycled plastic pallets, which provide logistical solutions required by a wide array of industries. These industries include food and beverage, agricultural, automotive, chemical, as well as pharmaceutical and consumer products.

Greystone Logistics’ shares trade on the OTC Markets’ OTCQB.The Company was previously known as PalWeb Corp.They changed their corporate name to Greystone Logistics, Inc. in March of 2005.Greystone serves beverage, pharmaceutical, and other industries.

The Company's technology, including that used in their injection molding equipment, and their proprietary blend of recycled plastic resins and patented pallet designs, allows production of high-quality pallets quickly and at lower costs than a number of processes. The recycled plastic for Greystone Logistics’ pallets helps control material costs; this is while reducing environmental waste. It provides cost advantages over users of virgin resin. The excess plastic not used in the production of pallets undergoes reprocessing for resale.

Pertaining toprocuringor selling resin or excess plastic, Greystone purchases HDPE scrap, pellets, purchings, dust, shavings and parts.  They occasionallysell some excess pelletized Santoprene, HDPE and comingled-baled scrap TPU and ABS car bumpers. The Company is the largest 100 percent recycled plastic pallet manufacturer in the U.S.

The Company’s products include rackable, nestable, display, monoblock, and stackable pallets. Products additionally include picture frame web-top pallets and web-top pallets. In addition, Greystone sells recycled plastic that undergoes reprocessing into pellet form. The Company also provides pallet leasing services.

Greystone offers recycled pallets for sale including full picture frame and three skids models ranging in size from 40x32 to 37x32, 48x40, 48x44, 37x37, 48x48, 44x56, 24x40, 36x36, 48x45 and IBC pallets. They keep inventory of faster moving recycled pallets for sale in stock for immediate shipment.

Plastic pallets last 10-50 times longer than wood;have residual (trade-in) value; arerecyclable; have ahigh coefficient of friction with anti-skid design for top, bottom, and fork lift tine contact;have substantially lower life cycle costs (cost per trip), and are suitedfor closed loop systems. Plastic pallets haveno exposed nails, wood chips, or broken boards on manufacturing or warehouse floors, which prevents fork lift issues.

Greystone Logistics, Inc. (GLGI), closed Friday at $0.389, up 2.37%, on 41,198 volume with 11 trades. The average volume for the last 60 days is 112,996 and the stock's 52-week low/high is $0.18/$0.7062.

Decision Diagnostics Corp. (DECN)

Stockoutlaws, Investor Ideas, Investor Stock Alerts, and OTCPicks reported on Decision Diagnostics Corp. (DECN), and we arehighlighting the Company, here at the QualityStocks Daily Newsletter.

Founded in 2000, Decision Diagnostics Corp. is developing products that offer inventivesolutions in medical care and management through providing physicians with essential information at the point of care. The Company formerly went by the name InstaCare Corp. They changed their corporate name to Decision Diagnostics Corp. in November 2011. The Company, based in Westlake Village, California, lists on the OTCQB.

Decision Diagnostics is a leadingprovider of prescription drugs and home testing products for the chronically ill. The Company is also a leading fulfillment provider of direct to patient diabetes programs, and a foremostdeveloper of novelcell phone centric e-health products and technologies.Decision Diagnostics’ products include glucose monitoring systems, wound care and ostomy products, and the Shasta GenStrip.

The Shasta Genstrip is for at-home testing of blood glucose. It fits into a diagnostic product niche and is for the worldwide self-test (home test) market. Decision Diagnostics is the exclusive worldwide sales, service, and regulatory processes agent for the Shasta GenStrip™, the Green Glucose Test Strip, specifically designed to work with Johnson & Johnson's LifeScan Ultra family of glucose testing meters.

Additionally, the Company offers information technology solutions in many medical care market channels. Their products make use of smart cell phones and an extensivecollectionof Microsoft Windows based smart phones and operates in a wireless or "wired" mode. Decision Diagnostics utilizes these smart phones, which permit physicians to carry, access, as well as update their patients' histories, medication data, and best care guidelines, all at the point of care.

The Company offers ResidenceWare - a collection of Internet-enhanced communication, integration, and networking tools developed for the real estate marketplace. Moreover, they offer MD@Hand - a smartphone application that leverages the connectivity of handheld devices through the Internet. Furthermore, Decision Diagnostics has their Practice Probe. The work of Practice Probe is as a data mining utility used to extract information from the physician's Practice Management System and to use that information in MD@Hand.

At the end of May,Decision Diagnostics announced that they and their subsidiary PharmaTech Solutions, Inc. launched a strategically packaged version of the Shasta GenStrip™ for sale to companies who service the "direct to patient" fulfillment (mail order and durable medical goods) channels.The estimation is that this channelwillcommand a share in excess of 25 percent of all diabetes testing.

At the beginning of August, Decision Diagnostics announced the filing of counterclaims by their subsidiary PharmaTech Solutionsfor false and misleading advertising against two of Johnson & Johnson, Inc. wholly owned subsidiaries, Lifescan, Inc., and Lifescan Scotland, LTD. The Company and their Pharma Tech Solutions subsidiary have been in patent litigation with the Lifescan subsidiaries since September 2011.

Decision Diagnostics Corp. (DECN), closed Friday’s trading session at $0.19, down 1.30%, on 144,371 volume with 21 trades. The average volume for the last 60 days is 56,843 and the stock's 52-week low/high is $0.052/$0.40.

graphic

The QualityStocks
Company Corner

graphic
graphic

On the Move Systems, Inc. (OMVS)

The QualityStocks Daily Newsletter would like to spotlight On the Move Systems, Inc. (OMVS). Today, On the Move Systems, Inc. closed trading at $0.18, up 24.14%, on 350,551 volume with 78 trades. The stock’s average daily volume over the past 60 days is 53,110, and its 52-week low/high is $0.0027/$0.185.

On the Move Systems, Inc. (OMVS) has established a scalable business model for leveraging the available routes and “legs” of private aviation to book private air charter, freight, and animal/exotic transport services. Their unique ISTx software is designed for managing and supporting services and routes across multiple private/commercial carriers through this single platform.

Management places strong emphasis on customer satisfaction and approaches this viewpoint by creating a unique flight or service profile for each client. The company has developed a business model offering this profile access through various proprietary and membership models. Additionally, its business strategy incorporates acquiring or joining with smaller charter plane owners. The company has further established various divisions which address particular client needs and routes. Leveraging its unique business model with a host of innovative solutions for expanding markets, OMVS is well positioned for rapid growth.

Current divisions of OMVS include Charter Services, Inter-Modal Freight, and Animal/Exotic Transport. The Charter Services Division offers private charter airplane owners the opportunity to enter a network where available planes will be "on-call" to deliver private air charter service on demand. The Inter-Modal Freight Division provides charter and freight shipping services to clients who need to expedite shipment of cargo and freight globally – including medical transport for tissue and isotopes. The company's Animal/Exotic Transport Division affords clients the security of transporting pets and animals without the accompaniment of the owner.

OMVS continues to develop technology and applications that connect all business touch points - passengers, assets, and routes. The company intends to monitor daily operations through a single platform providing ultimate support for all business activities. OMVS is in the final stages of development with the ISTx platform and plans to implement system wide in the next two fiscal quarters. Disclaimer

On the Move Systems, Inc. Company Blog

On the Move Systems, Inc. News:

OMVS Proceeds with Development of Groundbreaking Transportation Portal

OMVS Lines Up New Acquisition Targets in $300 Billion Online Transportation Industry

OMVS Officially Relaunches with New Transportation Business Model

Mabwe Minerals Inc. (MBMI)

The QualityStocks Daily Newsletter would like to spotlight Mabwe Minerals Inc. (MBMI). Today, Mabwe Minerals Inc. closed trading at $0.50, up 2.04%, on 22,620 volume with 5 trades. The stock’s average daily volume over the past 60 days is 17,357, and its 52-week low/high is $0.06/$0.70.

Mabwe Minerals Inc. (MBMI) is a U.S. based natural resources and hard asset company focused on the mining, logistics, and commercial sales of industrial minerals and metals, with a particular emphasis on barite. The company's operations are conducted through its Zimbabwe affiliate, Mabwe Mineral Zimbabwe (Private) Ltd. Transitioning into commercial production, MBMI's company fundamentals are well positioned with virtually no debt and key strategic partnerships in place.

Along with its affiliate, Mabwe Minerals Zimbabwe (Private) Ltd., an indigenous Zimbabwe company, the company owns 100% of the mineral & metal rights to Dodge Mine. The mine will be managed by the company's minority owned partner, WGB Kinsey & Company, Zimbabwe's most experienced mining & construction company representing four generations of Kinsey leadership. Management believes WGB Kinsey & Company has all the necessary equipment and management experience to efficiently perform all the mining operations at Dodge Mine.

The Dodge Mine property consists of three hydrothermal mountains representing 123 hectares containing multiple deposits of superior-grade barite, limestone, and talc. Hydrothermal barite deposits throughout Dodge Mine represent the highest grade of new barite sources to be brought into commercial production in years. A third party oil & gas drilling sector geologist recently confirmed that the multiple barite deposits are considered "World Class" in quality and highly efficient to mine via open pit extraction following the barite veins and salvaging large percentages of barite within the halo zones via jigging systems.

With a continuing worldwide shortage of high-grade barite, Mabwe Minerals is in the right place at the right time. The company's current customer uses barite as a weighting agent in oil & gas drilling applications in the Gulf of Mexico, home to the largest concentration of active rigs in the world. Coupled with the recent massive discovery of oil & gas off the coast of neighboring Mozambique along with new drilling contracts expected in the region, MBMI is in an attractive geographical location to capture the expected demands of this emerging market. Moving from an exploration stage company into commercial barite production, Mabwe Minerals is well positioned to generate significant shareholder returns. Disclaimer

Mabwe Minerals Inc. Company Blog

Mabwe Minerals Inc. News:

Mabwe Minerals Completes Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.

Mabwe Minerals Commences Mining Operations at Dodge Mine

Mabwe Minerals Frames Strategic Alliances With Steinbock Minerals Ltd. and Yasheya Ltd.

NanoTech Entertainment, Inc. (NTEK)

The QualityStocks Daily Newsletter would like to spotlight NanoTech Entertainment, Inc. (NTEK). Today, NanoTech Entertainment, Inc. closed trading at $0.0865, up 9.63%, on 6,884,603 volume with 400 trades. The stock’s average daily volume over the past 60 days is 9,011,187, and its 52-week low/high is $0.0005/$0.1395.

NanoTech Entertainment, Inc. (NTEK) is a conglomerate of entertainment companies focused on leveraging technology to deliver state-of-the-art entertainment and communications products. The company’s team is comprised of senior individuals who have been in the entertainment industry for more than 20 years and have a long track record of creating successful products.

Leveraging a diverse portfolio of products and technology, NanoTech is redefining the role of developers and manufacturers in the global market. The company has a unique business model with four technology business units focusing on gaming, media & IPTV, mobile apps, and manufacturing.

NanoTech’s Gaming Labs division operates as a virtual manufacturer, developing its technology and games, and licensing them to third parties for manufacturing and distribution in order to keep its overhead extremely low and operations efficient in the new global manufacturing economy. NanoTech Media develops proprietary technology which it licenses to publishers for use in their products as well as creating and publishing unique content. NanoTech Communications develops and sells proprietary apps and technology in the mobile and consumer space. Clear Memories is the global leader in 3D ice carving and manufacturing technology.

In a recent move to advance into the commercial media space, NanoTech signed a definitive agreement to acquire MagicScreen3D, a leader in the commercial implementation of glassless 3D screen technology. The company is focused on accelerating its corporate growth through additional acquisitions, licensing agreements, partnerships, and executing current business strategies. Leveraging its team’s expertise, NanoTech is well positioned to achieve greater success. Disclaimer

NanoTech Entertainment, Inc. Company Blog

NanoTech Entertainment, Inc. News:

NanoTech Entertainment Reports Record Quarterly and Annual Revenue

NanoTech Acquires Worldwide Global Entertainment

NanoTech Entertainment Completes Further Reduction of Nine Percent of Its Common Stock

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.151, up 7.09%, on 208,613 volume with 43 trades. The stock’s average daily volume over the past 60 days is 352,173, and its 52-week low/high is $0.13/$0.41.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.

A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.

In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Enters Into Clinical Research Agreement for Parkinson's Disease Program

International Stem Cell Corporation Announces Second Quarter 2013 Financial Results

Crystal Research Associates Issues Executive Informational Overview on International Stem Cell Corporation

Rafarma Pharmaceuticals, Inc. (RAFA) Leads the Charge against Big Pharma

For years, the worldwide pharmaceutical stage has been dominated by the giant pharmaceutical companies of North America and Europe. With the exception of Japan, now a major player, medicinal drug production has been concentrated in the U.S., Germany, France, and the UK. Given a global market size approaching a trillion dollars, the pharmaceutical market represents an irresistible opportunity that is now being pursued by other parts of world. China and India represent huge markets for lower-end pharmaceuticals, and the African pharmaceutical market is approaching $30 billion. Having hundreds of millions of people dependent upon a relative handful of countries and producers has become a source of concern for many governments.

In Russia, the government has taken the situation so seriously that it has pursued a number of programs to encourage the growth of its own pharmaceutical industry. In 2010, Russia’s then-President Dmitry Medvedev called for measures to further develop the domestic pharmaceutical industry and reduce the country’s dependence on foreign medicine. The initiative was echoed a year later by Vladimir Putin. Plans now call for $39 billion in financing in support of biotechnology under the umbrella of what is called the “The Comprehensive Program for Development of Biotechnology in the Russian Federation through 2020.”

Rafarma Pharmaceuticals has been one of the big beneficiaries of this movement, with the immediate result being the construction of the most technologically advanced pharmaceutical plant in Russia. The company has since been accelerating plans to produce a variety of generic pharmaceuticals, all part of the plan to greatly reduce the retail price of the most widely used drugs, freeing the country from the stranglehold of big pharma. Rafarma has, among other agreements, already been contracted for the production of the anti-cancer drug Imatinib and the anti-tuberculosis drug Para-Aminosalicylic Acid, as well as producing its own lines. The company is also actively developing a number of research and distribution agreements.

For more information, visit www.Rafarma.com

Premier Biomedical, Inc. (BIEL) Seeking International Patent Application for Technology to Treat Multiple Sclerosis

Premier Biomedical is a research-based company that intends to discover and develop medical treatments for a variety of disease such as multiple sclerosis, is pursuing an international patent application for its core technology to treat multiple sclerosis (MS). The company has already registered its technology in the United States and a Europe National Patent in the areas of cancer, blood sepsis, and Alzheimer’s disease, bringing the company’s patent portfolio to a total of nine provisional patent applications and six international patent applications.

Premier has structured the development of this therapy, which is functionally similar to the technology it has developed for the treatment of traumatic brain injury, cancer, and Alzheimer’s disease, to occur through the company’s existing research channels.

MS treatment is costly, with estimates that lifetime treatment of the disease costs each patient roughly $1.2 million. Premier reports that approximately 400,000 diagnosed cases of MS within the United States alone; on a worldwide basis, there are nearly 2.5 million confirmed cases of MS.

“Multiple sclerosis is a devastating disease which has destroyed the lives of many tens of thousands of patients,” Dr. Mitchell S. Felder, chairman of Premier’s Scientific Advisory Board stated in the press release. “We believe that Premier Biomedical is on the path to make a very major breakthrough in defeating this illness.”

Company president and CEO William A. Hartman noted that the company’s research and development relationships with the University of Texas at El Paso (UTEP) and the U.S. Department of Defense have increased the company’s capabilities and enabled the production of several “remarkably exciting and groundbreaking medical developments” that the company believes are positioned to advance the current medical industry.

He continued, “Our medical premise on MS and other diseases is sound: To physically remove the pathophysiologic basis of the disease via extra-corporeal means (i.e., outside the body) without potential dangerous side-effects. I invite any person or organization interested in the rapid development of an available cure for multiple sclerosis or any other major disease to reach out to Premier Biomedical to seek opportunities to participate with us in completing the R&D necessary to bring about the conversion from a laboratory cure to an available medical cure.”

For more information, visit www.premierbiomedicalinc.com

ERF Wireless, Inc. (ERFB) Increases Customer Base with Continued Expansion of High Speed Internet Service

ERF Wireless provides crucial infrastructure wireless broadband communications products and services to a broad range of customers in mainly rural oil and gas exploration areas of North America. The company also delivers high quality broadband services – an essential means of communication services – to residential, oil and gas, educational, health care, and regional banks in rural areas. ERF Wireless has followed a business strategy to acquire the best wireless broadband service companies in order to provide high-speed internet service to private entities, cities, municipalities, and the public.

ERF Wireless employs a business strategy that has shifted the company into a leading position in the United States as one of the largest WISP’s. Additionally, ERF Wireless has recently concentrated its focus on using its networks to provide large-scale wireless broadband to regional healthcare facilities and education institutions. The company plans to continue its resilient strategy of building and operating wireless broadband networks through a mixture of acquisitions, strategic partnerships, and new network construction.

Energy Broadband, Inc. (EBI) is the division of ERF that facilitates communication channels to remote areas where, in the past, the ability to communicate effectively and rapidly had been non-existent. This development has provided drilling operations and exploration activities the very important advantage of communicating and strategizing with remote offices and field personnel, therby reducing operating expenses and increasing sales revenue.

The ERF Wireless Internet Service Provider (WISP) Division presents customized technology solutions for business customers by employing network professionals responsible for custom-design, implementation, and maintenance of networks in several locations. It also offers partnerships with Microsoft, Dell, Cisco, and certifications that are recognized and accepted in the industry. This particular division also delivers an essential product called erfVault, which is an affordable online backup solution process for businesses.

ERF Wireless filed its form 10-Q with the SEC reporting results for the quarter ending June 30, 2013. The company’s financial results indicate its continuous business strategy and investment in delivering network and communication services to the oil and gas industry. The company reported overall consolidated revenues of $1,563,000 for the quarter ending June 30, 2013. Importantly, the company indicated increases in its customer growth base and enterprise network services with the addition of bank branches. The company’s Energy Broadband subsidiary reported revenues of $2,014,000 for the six months ending June 30, 2013. The company remained constant in its Gross Profit margins over the 12-month period ending June 30, 2013.

ERF is comprised of four divisions supplying wireless broadband product and services: Enterprise Network Services (Banks, Educational Institutions, and Healthcare Facilities), Bundled Wireless Services (WISP), Network Operations (overall Operational Support), and Wireless Messaging Services (Product Manufacturing and Maintenance). The company also claims the wholly owned subsidiary, Energy Broadband, Inc. (Oil & Gas). Complete information can be found at the company websites:www.erfwireless.comwww.energybroadband.com, and www.erfwireless.net.

Augme Technologies, Inc. (AUGT) Announces Official Name Change to Hipcricket, Inc., Begins Trading Under New Symbol

Today, interactive media, mobile marketing, and mobile advertising technology and services leader Augme Technologies announced the change of its name to Hipcricket, Inc., effective as of the close of business today. The company’s common stock will be henceforth quoted on the OTCBB and OTCQB under the new symbol “HIPP.” The company intends to conduct business under the name Hipcricket going forward.

This formal name change is intended to more accurately reflect the vision, operations, and long-term goals of Augme Technologies. The company believes the Hipcricket name will provide broader market appeal, recognition, and scalability to foster growth and build long-term brand equity moving into the next chapter of business.

In connection with this name change, a new program will be introduced that will allow users to receive Hipcricket press release and coverage updates via text message directly to their mobile devices. To opt in to this program, text “NEWS” to 24474.

Augme Technologies, soon to be known as Hipcricket, is the provider of a unified mobile engagement platform that drives awareness, sales, and loyalty. The company’s AD LIFE platform has been used by internationally recognized brands and agencies to power more than 250,000 campaigns across SMS, 2D/QR codes, mobile Web sites, advertising networks, social media, and branded apps. Headquartered in Kirkland, Wash., the company also has operations in New York City, Atlanta, Dallas, Los Angeles, San Francisco, Chicago, and Miami.

For more information, visit www.hipcricket.com

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

PennyStockLocks.com
(GCIH)

2.

Penny Stock Gainers
(UWRL)

3.

PREPUMP STOCKS
(REVI)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251